Group One Trading
BLCM

Group One Trading’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Group One Trading’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40,400
Closed -$300K – 6698
2020
Q2 		$300K Sell
40,400
-8,700
-18% -$59.2K ﹤0.01% 3047
2020
Q1 		$228K Buy
+49,100
New +$527K ﹤0.01% 2653
2019
Q1 		– Sell
-1,180
Closed -$34K – 5529
2018
Q4 		$34K Sell
1,180
-120
-9% -$5.32K ﹤0.01% 3755
2018
Q3 		$80K Sell
1,300
-120
-8% -$8.12K ﹤0.01% 3681
2018
Q2 		$105K Sell
1,420
-830
-37% -$64.7K ﹤0.01% 3531
2018
Q1 		$148K Sell
2,250
-190
-8% -$14.3K ﹤0.01% 2997
2017
Q4 		$205K Buy
2,440
+1,820
+294% +$178K ﹤0.01% 2915
2017
Q3 		$72K Buy
620
+300
+94% +$31.6K ﹤0.01% 3435
2017
Q2 		$37K Sell
320
-130
-29% -$16.1K ﹤0.01% 3656
2017
Q1 		$56K Buy
+450
New +$58.9K ﹤0.01% 3334

Other funds holding BLCM

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Group One Trading's BLCM Position: Q2 2023 in Review

Group One Trading sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 1,066 shares — an estimated $352 sold.

Group One Trading first reported a position in BLCM in Q2 2015 and held it in 27 quarters. The position peaked at $215K in Q3 2017. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

  • Group One Trading reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Group One Trading sold 1,066 Bellicum Pharmaceuticals, Inc. shares in Q2 2023, an estimated $352.
  • Group One Trading first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2015 and held it in 27 quarters.
  • Group One Trading's Bellicum Pharmaceuticals, Inc. position peaked at $215K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.